Daily Patent & CI news: 20/10/2010


Cipla launches Pirfenidone in india (BS), (Livemint)

Pirfenidone is an orally active, small molecule drug, used to treat Idiopathic Pulmonary Fibrosis (IPF). InterMune licensed certain rights to pirfenidone from Marnac, Inc. and its co-licensor, KDL GmbH, in 2002. In 2007 the company purchased from Marnac and KDL the rights to sell the compound under the patents in the United States, Europe and other territories, except in Japan, Taiwan and South Korea, where rights to the molecule were licensed to Shionogi & Co. Ltd. of Japan. In October of 2008, pirfenidone was approved for use in Japan for patients with idiopathic pulmonary fibrosis (IPF), where it is marketed as Pirespa® by Shionogi & Co. (Details)

Pfizer acquires 40% stake in Laboratorio Teuto Brasileiro S.A in Brazil (Press Release)

Sanofi and BMS won the patent infringement case against Apotex; Damages awarded up to $ 442 millon (Bloomberg)

Advertisements

About Guna

Interested to learn things around me
This entry was posted in Daily interesting IP news. Bookmark the permalink.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s